174 related articles for article (PubMed ID: 28380244)
21. Unusual phenobarbitone sensitivity.
Bakshi S; Bhakoo ON
Indian J Pediatr; 1971 Sep; 38(284):372-4. PubMed ID: 4258879
[No Abstract] [Full Text] [Related]
22. Eczematous drug reaction from phenobarbitone.
Fernández de Corres L; Leanizbarrutia I; Muñoz D
Contact Dermatitis; 1984 Nov; 11(5):319. PubMed ID: 6241128
[No Abstract] [Full Text] [Related]
23. Enduring large use of acetaminophen suppositories for fever management in children: a national survey of French parents and healthcare professionals' practices.
Bertille N; Fournier-Charrière E; Pons G; Khoshnood B; Chalumeau M
Eur J Pediatr; 2016 Jul; 175(7):987-92. PubMed ID: 27193104
[TBL] [Abstract][Full Text] [Related]
24. [Cross-hypersensitivity syndrome between antiepileptic drugs: report of a case].
Allende Bandrés MA; Izuel Rami M; Urbieta Sanz E; Villar Fernández I; Carcelén Andrés J
Farm Hosp; 2004; 28(1):56-8. PubMed ID: 15012179
[TBL] [Abstract][Full Text] [Related]
25. Hypersensitivity reaction to anticonvulsants following head injury.
Hassett JM; Doolittle T; Molloy M; Lalka D
N Y State J Med; 1987 Oct; 87(10):571-3. PubMed ID: 2960919
[No Abstract] [Full Text] [Related]
26. [Antipyretic effect of togal suppositories for children].
Preidel H
Med Monatsschr; 1970 Jul; 24(7):318-9. PubMed ID: 5512630
[No Abstract] [Full Text] [Related]
27. Fixed drug eruption: a selective reaction to amoxicillin.
Chaabane A; Fredj NB; Chadly Z; Boughattas NA; Aouam K
Therapie; 2013; 68(3):183-5. PubMed ID: 23886467
[No Abstract] [Full Text] [Related]
28. Paracetamol suppositories: a comparative study.
Cullen S; Kenny D; Ward OC; Sabra K
Arch Dis Child; 1989 Oct; 64(10):1504-5. PubMed ID: 2817936
[TBL] [Abstract][Full Text] [Related]
29. The medical treatment of epilepsy: managing side effects of antiepileptic drugs.
Livingston S; Pruce I; Pauli LL; Livingston HL
Pediatr Ann; 1979 Apr; 8(4):261-6. PubMed ID: 156906
[No Abstract] [Full Text] [Related]
30. Pentobarbital desensitization in a 3-month-old child.
Butte MJ; Dodson B; Dioun A
Allergy Asthma Proc; 2004; 25(4):225-7. PubMed ID: 15510580
[TBL] [Abstract][Full Text] [Related]
31. Premarketing surveillance of ibuprofen suppositories in febrile children.
Hadas D; Youngster I; Cohen A; Leibovitch E; Shavit I; Erez I; Uziel Y; Berkovitch M
Clin Pediatr (Phila); 2011 Mar; 50(3):196-9. PubMed ID: 21224250
[TBL] [Abstract][Full Text] [Related]
32. [Drug eruptions in children in Cotonou, Benin].
Adegbidi H; Atadokpede F; Sagbo G; Koudoukpo C; D'Almeida M; Teclessou J; N'Dah P; Djoonyam A Eroume AT; Yedomon HG; Do Ango-Padonou F
Mali Med; 2012; 27(1):42-6. PubMed ID: 22947321
[TBL] [Abstract][Full Text] [Related]
33. Drug rash with eosinophilia and systemic symptoms syndrome associated with use of phenytoin, divalproex sodium, and phenobarbital.
Brizendine CE; Naik PJ
Am J Health Syst Pharm; 2013 Mar; 70(6):507-10. PubMed ID: 23456403
[TBL] [Abstract][Full Text] [Related]
34. Determinants of antipyretic misuse in children up to 5 years of age: a cross-sectional study.
Bilenko N; Tessler H; Okbe R; Press J; Gorodischer R
Clin Ther; 2006 May; 28(5):783-93. PubMed ID: 16861100
[TBL] [Abstract][Full Text] [Related]
35. Bioavailability of phenobarbital by rectal administration.
Matsukura M; Higashi A; Ikeda T; Matsuda I
Pediatr Pharmacol (New York); 1981; 1(3):259-65. PubMed ID: 7346746
[TBL] [Abstract][Full Text] [Related]
36. Biopharmaceutical investigation of rectal suppositories. Part 2(1): Pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium.
Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
Pharmazie; 1985 Apr; 40(4):257-9. PubMed ID: 3839310
[TBL] [Abstract][Full Text] [Related]
37. Clinical experience and results of treatment with suprofen in pediatrics. 2nd communication: Use of suprofen suppositories as an antipyretic in children with fever due to acute infections/A single-blind controlled study of suprofen versus paracetamol.
Weippl G; Michos N; Sundal EJ; Stocker H
Arzneimittelforschung; 1985; 35(11):1724-7. PubMed ID: 3911962
[TBL] [Abstract][Full Text] [Related]
38. [Kinetics of release from suppositories formulated with phenobarbital acid or sodium, and semi-synthetic glyceride (Witepsol H 15). I. Freshly prepared suppositories].
Lasserre Y; Peneva B; Jacob M; Puech A
Pharm Acta Helv; 1984; 59(3):77-9. PubMed ID: 6718438
[No Abstract] [Full Text] [Related]
39. EMPACT syndrome associated with phenobarbital.
Fabbrocini G; Panariello L; Pensabene M; Lauria R; Matano E; Martellotta D; Bianca D; De Placido S; Ayala F
Dermatitis; 2013; 24(1):37-9. PubMed ID: 23340399
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of the antipyretic effect of imadyl in children's pills and suppositories. Double-blind versus placebo comparison].
Pecco P; Ballario R; Bonicatto L; Gabutti D
Minerva Pediatr; 1983 Dec; 35(23-24):1241-8. PubMed ID: 6674747
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
